House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government why patients who are immunocompromised must (1) test positive for COVID-19, (2) have no detectable antibodies for COVID-19, and (3) have been hospitalised specifically for acute symptoms of COVID-19, in order to access Ronapreve; and what plans they have to end this health inequality between immunocompromised patients and the rest of the population.  HL4093

Question HL4093: tabled on 16 November 2021 and due for answer by 30 November 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government why patients who are immunocompromised must (1) test positive for COVID-19, (2) have no detectable antibodies for COVID-19, and (3) have been hospitalised specifically for acute symptoms of COVID-19, in order to access Ronapreve; and what plans they have to end this health inequality between immunocompromised patients and the rest of the population.  HL4093
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer